Who invested in Symic Bio

2 rounds we have observed, with the 5 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$41Mraised across 2 rounds since 2017, from 3 sources

$30MSeries B$11MSeries C

Latest round: Series C, $11MApr 2019
Biggest round: $30MSeries B · May 2017
Investors: 5

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

20182019

$30MSeries B$11MSeries C

First round: Series B, $30M
Biggest round: $30M
Between rounds: 23 months

The rounds

Apr 2019
Series C$11M4 new
- National Science Foundation
- National Institutes of Health
- Mission BioCapital
- Cell Innovation Partners
Reported by FinSMEs and 1 other
May 2017
Series B$30M1 new
- HEDA Ventures
Reported by FinSMEs

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Series B2017Series C2019

National Science Foundation

National Institutes of Health

Mission BioCapital

HEDA VenturesCell Innovation Partners

Everyone who backed them

National Science FoundationGovernment1round

National Institutes of HealthGovernment1round

Mission BioCapitalVC firm1round

HEDA VenturesVC firm1round

Cell Innovation Partnersno record of our own yet1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Symic Bio

Who invested in Symic Bio?

Symic Bio's investors include National Science Foundation, National Institutes of Health, Mission BioCapital, HEDA Ventures and Cell Innovation Partners.